1. Mahlen SD.
Serratia infections: from military experiments to current practice. Clin Microbiol Rev. 2011; 24:755–791. PMID:
21976608.
2. Yang HF, Cheng J, Hu LF, Ye Y, Li JB. Plasmid-mediated quinolone resistance in extended-spectrum-β-lactamase- and AmpC β-lactamase-producing
Serratia marcescens in China. Antimicrob Agents Chemother. 2012; 56:4529–4531. PMID:
22664965.
3. Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother. 2003; 51:1109–1117. PMID:
12697644.
Article
4. Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev. 2009; 22:664–689. PMID:
19822894.
Article
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, Twenty-Second Informational supplement, M100-S22. Wayne, PA: CLSI;2012.
6. Ruiz J, Pons MJ, Gomes C. Transferable mechanisms of quinolone resistance. Int J Antimicrob Agents. 2012; 40:196–203. PMID:
22831841.
Article
7. Sato T, Yokota S, Uchida I, Okubo T, Ishihara K, Fujii N, et al. A fluoroquinolone-resistant
Escherichia coli clinical isolate without quinolone resistance-determining region mutations found in Japan. Antimicrob Agents Chemother. 2011; 55:3964–3965. PMID:
21670180.
8. Chopra S. A fluoroquinolone-resistant
Acinetobacter baumannii without the quinolone resistance-determining region mutations. J Antimicrob Chemother. 2011; 66:2668–2670. PMID:
21903661.